2022
DOI: 10.1016/j.jviromet.2021.114333
|View full text |Cite
|
Sign up to set email alerts
|

A low-cost TaqMan minor groove binder probe-based one-step RT-qPCR assay for rapid identification of N501Y variants of SARS-CoV-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 13 publications
0
9
0
Order By: Relevance
“…Commercial PCR kits for variant detection are currently available. However, these kits also target a few mutation markers originating from SARS-CoV-2 lineages of interest ( 23 25 ). As we showed above, targeting a single mutation might make the assay less accurate in certain regions due to the presence of other lineages that have the same mutation.…”
Section: Discussionmentioning
confidence: 99%
“…Commercial PCR kits for variant detection are currently available. However, these kits also target a few mutation markers originating from SARS-CoV-2 lineages of interest ( 23 25 ). As we showed above, targeting a single mutation might make the assay less accurate in certain regions due to the presence of other lineages that have the same mutation.…”
Section: Discussionmentioning
confidence: 99%
“…Additional confidence in prevalence of VOCs is provided by the fact that the mutation and Universal signals can be quantified using the same standard. In comparison, other VOC qPCR assays estimate prevalence by comparing a mutant allele to a genetic marker of SARS-COV-2 in another amplicon, /genetic locus such as the CDC_N1 (Vogels et al, 2021; Wolfe et al, 2021), or by comparing the frequencies of the mutant and “wild-type” (e.g., ancestral/endemic allele) at the same locus (Chan et al, 2022; Graber et al, 2021; Lee et al, 2021; Peterson et al, 2022). While these assays can produce accurate data (from both analytical and clinical perspectives), there are additional controls needed to account for variations in efficiencies of variation (inter- assay variability and matching standard quantities), that are eliminated by the N200 assay.…”
Section: Discussionmentioning
confidence: 99%
“…or by comparing the frequencies of the mutant and "wild-type" (e.g., ancestral/endemic allele) at the same locus (Chan et al, 2022;Graber et al, 2021;Lee et al, 2021;Peterson et al, 2022).…”
Section: Discussionmentioning
confidence: 99%
“…Alternative approaches to NGS for surveillance of VOCs and/or epidemiologically important mutations is a rapidly expanding area: commercially available molecular assays for SARS-CoV-2 VOCs have been developed, including the TIB MolBio ViRSNiP (26) tests, however these tests only identify a single SNP or deletion per assay, potentially requiring a panel of tests for comprehensive surveillance. Elsewhere, academic groups have developed assays for particular epidemiologically important mutations using either hydrolysis probes (27), molecular beacons (28) or isothermal methods (29). However, the HRM approach we present is the rst development of a comprehensive tool kit of primers that can be combined in response to local epidemiology, and furthermore is readily adaptable to the emergence of new VOCs, as demonstrated by the incorporation of primers for detection of the Omicron VOC in our assay.…”
Section: Discussionmentioning
confidence: 99%